Healthcare entity
Jefferies Financial Group is most often covered alongside AxoGen, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 166-day span. The 5 average consequence score is below the beat benchmark of 6 in the same window.
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Jefferies Financial Group is most often covered alongside AxoGen, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 166-day span. The 5 average consequence score is below the beat benchmark of 6 in the same window. Source depth averages 2 original sources per story, versus 3.7 across the same-window beat baseline. Coverage clusters in health-it, which accounts for 1 of those 2, with the remainder spread across 1 other category. Jefferies Financial Group appears in 2 tracked Healthcare stories published from February 21, 2026 through August 5, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 1012 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jefferies Financial Group. Shared-story counts are live from our verified record — not editorial picks.
Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline.
AxoGen (NASDAQ: AXGN) has received a significant rating upgrade to "Strong-Buy" from Wells Fargo, signaling robust institutional confidence in the peripheral nerve repair specialist. This move, coupled with price target hikes from Jefferies and positive outlooks from Citigroup, underscores a bullish sentiment for the company's clinical and commercial trajectory.
Source: Ticker Report · Watch List News
Jefferies Financial Group is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
